Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | KDM5C | P41229 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.38 |
| ▸ | KDM4A | O75164 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL742050 | 0.98 | CTSD (0.48) | CTSDPHF8KDM2AKDM4EKDM5C | |
| SCHEMBL406688 | 0.93 | CTSD (0.48) | CTSDPHF8KDM2AKDM4EKDM5C | |
| SCHEMBL11573513 | 0.91 | ALDH1A1 (0.50) | CTSDPHF8KDM2AKDM4EKDM5C | |
| SCHEMBL2828707 | 0.86 | — | — | |
| SCHEMBL28063028 | 0.84 | CTSD (0.48) | CTSDPHF8KDM2AKDM4EKDM5C | |
| SCHEMBL11653052 | 0.84 | CTSD (0.48) | CTSDPHF8KDM2AKDM4EKDM5C | |
| Hydrochloric Acid SCHEMBL6942259 | 0.84 | CTSD (0.52) | CTSDPHF8KDM2AKDM4EKDM5C | |
| SCHEMBL24311924 | 0.82 | LMNA (0.54) | CTSDALDH1A1GAALMNAPKM | |
| SCHEMBL5275835 | 0.79 | HDAC3 (0.56) | PHF8KDM2AKDM4EKDM5CCA1 | |
| SCHEMBL13223739 | 0.79 | LMNA (0.44) | PHF8KDM2ACA1KDM4CKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1135363-B1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | GREAT LAKES CHEMICAL EUROP (CH) | 2003-09-24 | — | — | EP | claimed |
| US-6444848-B1 | REACTING HYDRAZINE WITH ACID CHLORIDE | GREAT LAKES CHEMICAL (EUROPE) GMBH (DE) | 2002-09-03 | — | — | US | claimed |
| EP-1135363-A1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | Great Lakes Chemical (Europe) GmbH (CH) | 2001-09-26 | — | — | EP | claimed |
| WO-2000034227-A1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) | 2000-06-15 | — | — | WO | claimed |
| US-20160137639-A1 | TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2016-05-19 | — | — | US | disclosed |
| EP-1135363-B1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | GREAT LAKES CHEMICAL EUROP (CH) | 2003-09-24 | — | — | EP | disclosed |
| US-6444848-B1 | REACTING HYDRAZINE WITH ACID CHLORIDE | GREAT LAKES CHEMICAL (EUROPE) GMBH (DE) | 2002-09-03 | — | — | US | disclosed |
| EP-1135363-A1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | Great Lakes Chemical (Europe) GmbH (CH) | 2001-09-26 | — | — | EP | disclosed |
| WO-2000034227-A1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) | 2000-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137639-A1 | TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF | CYP3A7, CYP2C19, CYP3A5 | CTSD 3042/4885PHF8 1287/4885KDM2A 4218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.